hydroxychloroquine

Hydroxychloroquine Improves Vascular Outcomes in Patients with Systemic Lupus Erythematosus

Kaitlyn D’OnofrioThrombosis | September 6, 2023

Patients with systemic lupus erythematosus (SLE) taking hydroxychloroquine may also benefit from improved vascular ...

Oklahoma Wants To Return $2 Million Worth of Unused Hydroxychloroquine

Kaitlyn D’OnofrioCOVID-19 | April 6, 2023

The Oklahoma attorney general’s office is seeking to return $2 million worth of unused hydroxychloroquine, the drug ...

Rheum Round-up: Rheumatologists Weigh In On Hydroxychloroquine, Trump’s False Tweet, and more

Kaitlyn D’OnofrioRheumatology | January 29, 2021

Hydroxychloroquine has been the focus of many conversations during the COVID-19 pandemic, among patients and providers ...

COVID-19 Update: Biden Announces 200 Million More Vaccine Doses; WHO Begins Investigation into COVID's Origins; and More

Rob DillardOncology | January 27, 2021

On Wednesday, January 27, 2021, here are the latest COVID-19 numbers around the world, according to statistics ...

Trump’s False Hydroxychloroquine Tweet Led To Spread of COVID-19 Misinformation

Kaitlyn D’OnofrioCOVID-19 | April 6, 2023

A tweet from former President Donald J. Trump was linked to a surge of false information about hydroxychloroquine as a ...

Rheumatologists Weigh In On Hydroxychloroquine and COVID-19

Kaitlyn D’OnofrioCOVID-19 | April 6, 2023

Attempts to repurpose hydroxychloroquine as a treatment for additional indications, including COVID-19, are a testament ...

Rheum Round-up: Hydroxychloroquine, Arthritis and Alcohol, and more

Kaitlyn D’OnofrioRheumatology | January 15, 2021

In this week’s rheumatology round-up, read about the latest updates on hydroxychloroquine and two arthritis drugs ...

Hydroxychloroquine Versus Sulfasalazine: How Do These RA Drugs Compare in Risks of Suicide, Depression, Psychosis?

Kaitlyn D’OnofrioCOVID-19 | July 14, 2023

Questions about COVID-19 and potential treatments have been abundant among the community of patients with rheumatic diseases.

Hydroxychloroquine COVID-19 Study Paused Due to Lack of Participants

Kaitlyn D’OnofrioCOVID-19 | July 14, 2023

A trial investigating the use of hydroxychloroquine to treat patients with COVID-19 has quietly closed enrollment after ...

Rheum Round-up: Hydroxychloroquine Exposure and COVID-19 Risk, and Much More

Kaitlyn D’OnofrioRheumatology | December 18, 2020

Can Pre-exposure to Hydroxychloroquine Prevent COVID-19 in Patients with RA and SLE? ...

Can Pre-exposure to Hydroxychloroquine Prevent COVID-19 in Patients with RA and SLE?

Kaitlyn D’OnofrioCOVID-19 | April 7, 2023

At the onset of the COVID-19 pandemic, hydroxychloroquine became a hot topic as a possible treatment for the virus. ...

Interview: How Are Rheumatologists Handling the Misinformation Spreading During the COVID-19 Pandemic?

Kaitlyn D’OnofrioCOVID-19 | April 6, 2023

COVID-19 has presented significant challenges to the medical community—converting operations to telemedicine, ...

SLE Patients May Be Able to Safely Discontinue Hydroxychloroquine Without Increasing Flares

Kaitlyn D’OnofrioRheumatology | August 21, 2020

Many systemic lupus erythematosus (SLE) patients take hydroxychloroquine to help manage their disease. Benefits of the ...

Recap on How the Medical Field has Handled the Coronavirus (COVID-19) Outbreak

Kaitlyn D’OnofrioCOVID-19 | April 6, 2023

Updates on the COVID-19 pandemic have come out almost daily. Whether it’s social distancing guidelines, facemask ...

Low-dose Glucocorticoids Plus Methotrexate and Hydroxychloroquine Effective in Early RA

Kaitlyn D’OnofrioRheumatoid Arthritis | April 12, 2023

Glucocorticoids have been used in rheumatoid arthritis (RA) for decades and in recent years have been used as ...

HOT TAKE: Data Quality, Retractions, and What It Means for Medical Research

DocWire News EditorsPayal Kohli | April 25, 2023

Dr. Payal Kohli, a cardiologist based in Denver, CO, and section adviser for the Cardiology section of DocWire News, ...

Cardio Round-up: Lancet Retracts Hydroxychloroquine Study; Stroke Care Delayed Due to COVID-19; And More

DocWire News EditorsAtrial Fibrillation | June 5, 2020

Lancet Retracts Hydroxychloroquine Study, NEJM Publishes Expression of Concern ...

(UPDATE: LANCET RETRACTS STUDY) ... Journals Publish Expressions of Concern Regarding Hydroxychloroquine and ACE Inhibitor Studies in COVID-19 Patients

DocWire News EditorsCardiology | April 6, 2023

UPDATE 6-5-20 ...

Cardio Round-up: Hydroxychloroquine and Arrhythmia; Socioeconomic Status and CHD Burden; and More

DocWire News EditorsCardiology | July 5, 2023

...

Hydroxychloroquine Associated with Increased Risk for Arrhythmias: Study

DocWire News EditorsCardiology | April 12, 2023

A new analysis of multinational registry data suggests that hydroxychloroquine (or chloroquine) is associated with ...